BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Business

  PPD, Inc. Announces Plans to Spin off Compound Partnering Business

  October 28, 2009

   · 

  5 min read
• Business

  Morphotek Inc. Announces a Licensing Deal With Centocor Ortho Biotech Inc. for Exclusive Development and Commercialization Rights for a Therapeutic Monoclonal Antibody

  October 28, 2009

   · 

  2 min read
• Nabriva Therapeutics Raises $22 Million

  October 28, 2009

   · 

  1 min read
• FDA

  Novartis International AG Says EU Approves Inflammatory Disease Drug

  October 28, 2009

   · 

  1 min read
• Pharm Country

  Sanofi-Aventis (France) Gets FDA Warning Over Uroxatral Promotion

  October 28, 2009

   · 

  1 min read
• Policy

  Zogenix, Inc. and Desitin Pharmaceuticals GmbH Announce Filing for European Regulatory Approval of SUMAVEL(TM) DosePro(TM) - European Pivotal Trial Confirms Bioequivalence

  October 28, 2009

   · 

  3 min read
• Policy

  Regeneron Pharmaceuticals, Inc.'s Rilonacept Granted European Marketing Authorization for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)

  October 28, 2009

   · 

  2 min read
• Drug Development

  US FDA Panel Says More Study on Human Genome Sciences, Inc. (JOBS) Anthrax Drug

  October 28, 2009

   · 

  1 min read
• Bio NC

  PPD, Inc. to Invest $100 Million in Celtic Therapeutics

  October 28, 2009

   · 

  4 min read
• Business

  CNS Protein Therapeutics Completes Name Change to Amarantus Therapeutics, Appoints New CEO Martin D. Cleary

  October 28, 2009

   · 

  3 min read